HSPA5 and cancer: BOLD-100, sodium trans-[tetrachlorobis(1H-indazole) ruthenate(III)], is an intravenously administered small molecule compound that downregulates GRP78 expression by inhibiting its mRNA transcription across various cancer types [25–28].